Boston Scientific Corporation (0HOY.L)
0HOY.L Stock Price Chart
Explore Boston Scientific Corporation interactive price chart. Choose custom timeframes to analyze 0HOY.L price movements and trends.
0HOY.L Company Profile
Discover essential business fundamentals and corporate details for Boston Scientific Corporation (0HOY.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
29 Jan 2018
Employees
53.00K
Website
https://www.bostonscientific.comCEO
Michael F. Mahoney
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
0HOY.L Financial Timeline
Browse a chronological timeline of Boston Scientific Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 Apr 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 21 Oct 2025
Upcoming earnings on 22 Jul 2025
Revenue estimate is $4.89B.
Earnings released on 23 Apr 2025
EPS came in at $0.45 falling short of the estimated $0.67 by -32.93%, while revenue for the quarter reached $4.66B, missing expectations by -2.64%.
Earnings released on 5 Feb 2025
EPS came in at $0.38 falling short of the estimated $0.66 by -42.19%, while revenue for the quarter reached $4.56B, beating expectations by +3.16%.
Earnings released on 23 Oct 2024
EPS came in at $0.31 falling short of the estimated $0.59 by -46.50%, while revenue for the quarter reached $4.21B, beating expectations by +4.16%.
Earnings released on 24 Jul 2024
EPS came in at $0.22 falling short of the estimated $0.58 by -62.56%, while revenue for the quarter reached $4.12B, beating expectations by +2.26%.
Earnings released on 24 Apr 2024
EPS came in at $0.33 falling short of the estimated $0.51 by -35.14%, while revenue for the quarter reached $3.86B, beating expectations by +4.67%.
Earnings released on 6 Mar 2024
EPS came in at $0.34 falling short of the estimated $0.51 by -33.47%, while revenue for the quarter reached $3.73B, beating expectations by +3.67%.
Earnings released on 26 Oct 2023
EPS came in at $0.34 falling short of the estimated $0.48 by -28.41%, while revenue for the quarter reached $3.53B, beating expectations by +1.44%.
Earnings released on 27 Jul 2023
EPS came in at $0.19 falling short of the estimated $0.49 by -62.16%, while revenue for the quarter reached $3.60B, beating expectations by +2.76%.
Earnings released on 26 Apr 2023
EPS came in at $0.22 falling short of the estimated $0.43 by -49.82%, while revenue for the quarter reached $3.39B, beating expectations by +7.39%.
Earnings released on 1 Feb 2023
EPS came in at $0.10 falling short of the estimated $0.47 by -79.42%, while revenue for the quarter reached $3.24B, missing expectations by -0.04%.
Earnings released on 30 Sept 2022
EPS came in at $0.13 falling short of the estimated $0.44 by -70.41%, while revenue for the quarter reached $3.17B, beating expectations by +0.97%.
Earnings released on 30 Jun 2022
EPS came in at $0.18 falling short of the estimated $0.42 by -57.29%, while revenue for the quarter reached $3.24B, beating expectations by +0.86%.
Earnings released on 31 Mar 2022
EPS came in at $0.08 falling short of the estimated $0.38 by -79.95%, while revenue for the quarter reached $3.03B, beating expectations by +2.39%.
Dividend declared on 15 Mar 2022
A dividend of $0.29 per share was announced, adjusted to $0.29.
Earnings released on 31 Dec 2021
EPS came in at $0.07 falling short of the estimated $0.44 by -85.09%, while revenue for the quarter reached $3.13B, beating expectations by +0.50%.
Earnings released on 27 Oct 2021
EPS came in at $0.13, while revenue for the quarter reached $3.08B.
Earnings released on 30 Sept 2021
EPS came in at $0.29, while revenue for the quarter reached $2.93B.
Earnings released on 31 Mar 2021
EPS came in at $0.23, while revenue for the quarter reached $2.75B.
Earnings released on 31 Dec 2020
EPS came in at $0.14, while revenue for the quarter reached $2.71B.
Earnings released on 30 Sept 2020
EPS came in at -$0.12, while revenue for the quarter reached $2.66B.
0HOY.L Stock Performance
Access detailed 0HOY.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.